Robotic-assisted versus open pancreaticoduodenectomy for patients with benign and malignant periampullary disease: a systematic review and meta-analysis of short-term outcomes.

Meta-analysis Minimally invasive pancreaticoduodenectomy Pancreatic cancer Pancreaticoduodenectomy Periampullary cancer Robotic pancreaticoduodenectomy

Journal

Surgical endoscopy
ISSN: 1432-2218
Titre abrégé: Surg Endosc
Pays: Germany
ID NLM: 8806653

Informations de publication

Date de publication:
06 2020
Historique:
received: 07 06 2019
accepted: 11 02 2020
pubmed: 20 2 2020
medline: 28 5 2021
entrez: 20 2 2020
Statut: ppublish

Résumé

Although several non-randomized studies comparing robotic pancreaticoduodenectomy (RPD) and open pancreaticoduodenectomy (OPD) recently demonstrated that the two operative techniques could be equivalent in terms of safety outcomes and short-term oncologic efficacy, no definitive answer has arrived yet to the question as to whether robotic assistance can contribute to reducing the high rate of postoperative morbidity. Systematic literature search was performed using MEDLINE, the Cochrane Central Register of Controlled Trials, and EMBASE databases. Prospective and retrospective studies comparing RPD and OPD as surgical treatment for periampullary benign and malignant lesions were included in the systematic review and meta-analysis with no limits of language or year of publication. 18 non-randomized studies were included for quantitative synthesis with 13,639 patients allocated to RPD (n = 1593) or OPD (n = 12,046). RPD and OPD showed equivalent results in terms of mortality (3.3% vs 2.8%; P = 0.84), morbidity (64.4% vs 68.1%; P = 0.12), pancreatic fistula (17.9% vs 15.9%; P = 0.81), delayed gastric emptying (16.8% vs 16.1%; P = 0.98), hemorrhage (11% vs 14.6%; P = 0.43), and bile leak (5.1% vs 3.5%; P = 0.35). Estimated intra-operative blood loss was significantly lower in the RPD group (352.1 ± 174.1 vs 588.4 ± 219.4; P = 0.0003), whereas operative time was significantly longer for RPD compared to OPD (461.1 ± 84 vs 384.2 ± 73.8; P = 0.0004). RPD and OPD showed equivalent results in terms of retrieved lymph nodes (19.1 ± 9.9 vs 17.3 ± 9.9; P = 0.22) and positive margin status (13.3% vs 16.1%; P = 0.32). RPD is safe and feasible as surgical treatment for malignant or benign disease of the pancreatic head and the periampullary region. Equivalency in terms of surgical radicality including R0 curative resection and number of harvested lymph nodes between the two groups confirmed the reliability of RPD from an oncologic point of view.

Sections du résumé

BACKGROUND
Although several non-randomized studies comparing robotic pancreaticoduodenectomy (RPD) and open pancreaticoduodenectomy (OPD) recently demonstrated that the two operative techniques could be equivalent in terms of safety outcomes and short-term oncologic efficacy, no definitive answer has arrived yet to the question as to whether robotic assistance can contribute to reducing the high rate of postoperative morbidity.
METHODS
Systematic literature search was performed using MEDLINE, the Cochrane Central Register of Controlled Trials, and EMBASE databases. Prospective and retrospective studies comparing RPD and OPD as surgical treatment for periampullary benign and malignant lesions were included in the systematic review and meta-analysis with no limits of language or year of publication.
RESULTS
18 non-randomized studies were included for quantitative synthesis with 13,639 patients allocated to RPD (n = 1593) or OPD (n = 12,046). RPD and OPD showed equivalent results in terms of mortality (3.3% vs 2.8%; P = 0.84), morbidity (64.4% vs 68.1%; P = 0.12), pancreatic fistula (17.9% vs 15.9%; P = 0.81), delayed gastric emptying (16.8% vs 16.1%; P = 0.98), hemorrhage (11% vs 14.6%; P = 0.43), and bile leak (5.1% vs 3.5%; P = 0.35). Estimated intra-operative blood loss was significantly lower in the RPD group (352.1 ± 174.1 vs 588.4 ± 219.4; P = 0.0003), whereas operative time was significantly longer for RPD compared to OPD (461.1 ± 84 vs 384.2 ± 73.8; P = 0.0004). RPD and OPD showed equivalent results in terms of retrieved lymph nodes (19.1 ± 9.9 vs 17.3 ± 9.9; P = 0.22) and positive margin status (13.3% vs 16.1%; P = 0.32).
CONCLUSIONS
RPD is safe and feasible as surgical treatment for malignant or benign disease of the pancreatic head and the periampullary region. Equivalency in terms of surgical radicality including R0 curative resection and number of harvested lymph nodes between the two groups confirmed the reliability of RPD from an oncologic point of view.

Identifiants

pubmed: 32072286
doi: 10.1007/s00464-020-07460-4
pii: 10.1007/s00464-020-07460-4
doi:

Types de publication

Comparative Study Journal Article Meta-Analysis Systematic Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

2390-2409

Références

Acharya A, Markar SR, Sodergren MH et al (2017) Meta-analysis of adjuvant therapy following curative surgery for periampullary adenocarcinoma. Br J Surg 104:814–822
pubmed: 28518410
Gagner M, Pomp A (1994) Laparoscopic pylorus-preserving pancreatoduodenectomy. Surg Endosc 8:408–410
pubmed: 7915434
Nickel F, Haney CM, Kowalewski KF et al (2019) Laparoscopic versus open pancreaticoduodenectomy: a systematic review and meta-analysis of randomized controlled trials. Ann Surg. https://doi.org/10.1097/SLA.0000000000003309
doi: 10.1097/SLA.0000000000003309
Boggi U, Amorese G, Vistoli F et al (2015) Laparoscopic pancreaticoduodenectomy: a systematic literature review. Surg Endosc 29:9–23
pubmed: 25125092
Boggi U, Palladino S, Massimetti G et al (2015) Laparoscopic robot-assisted versus open total pancreatectomy: a case-matched study. Surg Endosc 29:1425–1432
pubmed: 25159652
Peng L, Lin S, Li Y et al (2017) Systematic review and meta-analysis of robotic versus open pancreaticoduodenectomy. Surg Endosc 31:3085–3097
pubmed: 27928665
Ricci C, Casadei R, Taffurelli G et al (2018) Minimally invasive pancreaticoduodenectomy: what is the best "Choice"? A systematic review and network meta-analysis of non-randomized comparative studies. World J Surg 42:788–805
pubmed: 28799046
Shin SH, Kim YJ, Song KB et al (2017) Totally laparoscopic or robot-assisted pancreaticoduodenectomy versus open surgery for periampullary neoplasms: separate systematic reviews and meta-analyses. Surg Endosc 31:3459–3474
pubmed: 28039645
Zhang J, Wu WM, You L et al (2013) Robotic versus open pancreatectomy: a systematic review and meta-analysis. Ann Surg Oncol 20:1774–1780
pubmed: 23504140
Klompmaker S, van Hilst J, Wellner UF et al (2018) Outcomes after minimally-invasive versus open pancreatoduodenectomy: a pan-European propensity score matched study. Ann Surg. https://doi.org/10.1097/SLA.0000000000002850
doi: 10.1097/SLA.0000000000002850
Zimmerman AM, Roye DG, Charpentier KP (2018) A comparison of outcomes between open, laparoscopic and robotic pancreaticoduodenectomy. HPB (Oxford) 20:364–369
Liberati A, Altman DG, Tetzlaff J et al (2009) The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. BMJ 339:b2700
pubmed: 2714672 pmcid: 2714672
Stroup DF, Berlin JA, Morton SC et al (2000) Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis of observational studies in epidemiology (MOOSE) group. JAMA 283:2008–2012
pubmed: 10789670
Higgins JPT, Green S (eds). Cochrane handbook for systematic reviews of interventions version 5.3.5. The cochrane collaboration, 2014. www.handbook.cochrane.org . Accessed April 2018.
Sterne JA, Herna’n MA, Reeves BC et al (2016) ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions. BMJ 355:i4919
pubmed: 27733354 pmcid: 5062054
Balshem H, Helfand M, Schünemann HJ et al (2011) GRADE guidelines: 3. Rating the quality of evidence. J Clin Epidemiol 64:401–406
pubmed: 21208779 pmcid: 21208779
Bassi C, Dervenis C, Butturini G et al (2005) Postoperative pancreatic fistula: an international study group (ISGPF) definition. Surgery 138:8–13
pubmed: 16003309
Bassi C, Marchegiani G, Dervenis C et al (2017) The 2016 update of the International Study Group (ISGPS) definition and grading of postoperative pancreatic fistula: 11 Years After. Surgery 161:584–591
pubmed: 28040257
Koch M, Garden OJ, Padbury R et al (2011) Bile leakage after hepatobiliary and pancreatic surgery: a definition and grading of severity by the International Study Group of Liver Surgery. Surgery 149:680–688
pubmed: 21316725
Wente MN, Bassi C, Dervenis C et al (2007) Delayed gastric emptying (DGE) after pancreatic surgery: a suggested definition by the International Study Group of Pancreatic Surgery (ISGPS). Surgery 142:761–768
pubmed: 17981197
Wente MN, Veit JA, Bassi C et al (2007) Postpancreatectomy hemorrhage (PPH): an International Study Group of Pancreatic Surgery (ISGPS) definition. Surgery 142:20–25
pubmed: 17629996
Hozo SP, Djulbegovic B, Hozo I (2005) Estimating the mean and variance from the median, range, and the size of a sample. BMC Med Res Methodol 5:13
pubmed: 1097734 pmcid: 1097734
DerSimonian R, Laird N (1986) Meta-analysis in clinical trials. Control Clin Trials 7:177–188
Boggi U, Napoli N, Costa F et al (2016) Robotic-assisted pancreatic resections. World J Surg 40:2497–2506
pubmed: 27206401
Walsh M, Chalikonda S, Saavedra JRA (2011) Laparoscopic robotic assisted Whipple: early results of a novel technique and comparison with the standard open procedure. Surg Endosc 25:S221
Kim H, Kim JR, Han Y et al (2017) Early experience of laparoscopic and robotic hybrid pancreaticoduodenectomy. Int J Med Robot. https://doi.org/10.1002/rcs.1814
doi: 10.1002/rcs.1814 pubmed: 29282850
Torphy RJ, Friedman C, Halpern A et al (2018) Comparing short-term and oncologic outcomes of minimally invasive versus open pancreaticoduodenectomy across low and high volume centers. Ann Surg. https://doi.org/10.1097/SLA.0000000000002810
doi: 10.1097/SLA.0000000000002810
Croome KP, Farnell MB, Que FG et al (2014) Total laparoscopic pancreaticoduodenectomy for pancreatic ductal adenocarcinoma: oncologic advantages over open approaches? Ann Surg 260:633–638
pubmed: 25203880
Adam MA, Choudhury K, Dinan MA et al (2015) Minimally invasive versus open pancreaticoduodenectomy for cancer: practice patterns and short-term outcomes among 7061 patients. Ann Surg 262:372–377
pubmed: 26158612
Hammill C, Cassera M, Swanstrom L et al (2010) Robotic assistance may provide the technical capability to perform a safe, minimally invasive pancreaticoduodenectomy. HPB (Oxford) 12:198
McMillan MT, Zureikat AH, Hogg ME et al (2017) A propensity score-matched analysis of robotic vs open pancreatoduodenectomy on incidence of pancreatic fistula. JAMA Surg 152:327–335
pubmed: 28030724 pmcid: 5470429
Zureikat AH, Postlewait LM, Liu Y et al (2016) A multi-institutional comparison of perioperative outcomes of robotic and open pancreaticoduodenectomy. Ann Surg 264:640–649
pubmed: 27433907
Kauffmann EF, Napoli N, Menonna F et al (2019) A propensity score-matched analysis of robotic versus open pancreatoduodenectomy for pancreatic cancer based on margin status. Surg Endosc 33:234–242
pubmed: 29943061
Girgis MD, Zenati MS, Steve J et al (2017) Robotic approach mitigates perioperative morbidity in obese patients following pancreaticoduodenectomy. HPB (Oxford) 19:93–98
Varley PR, Zenati MS, Klobuka A et al (2018) Does robotic pancreaticoduodenectomy improve outcomes in patients with high risk morphometric features compared to the open approach. HPB (Oxford). https://doi.org/10.1016/j.hpb.2018.10.016
doi: 10.1016/j.hpb.2018.10.016
Napoli N, Kauffmann EF, Menonna F et al (2018) Robotic versus open pancreatoduodenectomy: a propensity score-matched analysis based on factors predictive of postoperative pancreatic fistula. Surg Endosc 32:1234–1247
pubmed: 28812160
Baker EH, Ross SW, Seshadri R et al (2016) Robotic pancreaticoduodenectomy: comparison of complications and cost to the open approach. Int J Med Robot 12:554–560
pubmed: 26202591
Bao PQ, Mazirka PO, Watkins KT (2014) Retrospective comparison of robot-assisted minimally invasive versus open pancreaticoduodenectomy for periampullary neoplasms. J Gastrointest Surg 18:682–689
pubmed: 24234245
Buchs NC, Addeo P, Bianco FM et al (2011) Robotic versus open pancreaticoduodenectomy: a comparative study at a single institution. World J Surg 35:2739–2746
pubmed: 21947494
Zhou NX, Chen JZ, Liu Q et al (2011) Outcomes of pancreatoduodenectomy with robotic surgery versus open surgery. Int J Med Robot 7:131–137
pubmed: 21412963
Kim HS, Han Y, Kang JS et al (2018) Comparison of surgical outcomes between open and robot-assisted minimally invasive pancreaticoduodenectomy. J Hepatobiliary Pancreat Sci 25:142–149
pubmed: 29117639
Wang SE, Shyr BU, Chen SC et al (2018) Comparison between robotic and open pancreaticoduodenectomy with modified Blumgart pancreaticojejunostomy: a propensity score-matched study. Surgery 164:1162–1167
pubmed: 30093277
Chen S, Chen JZ, Zhan Q et al (2015) Robot-assisted laparoscopic versus open pancreaticoduodenectomy: a prospective, matched, mid-term follow-up study. Surg Endosc 29:3698–3711
pubmed: 25761559
Chalikonda S, Aguilar-Saavedra JR, Walsh RM (2012) Laparoscopic robotic-assisted pancreaticoduodenectomy: a case-matched comparison with open resection. Surg Endosc 26:2397–2402
pubmed: 22437947
Lai EC, Yang GP, Tang CN (2012) Robot-assisted laparoscopic pancreaticoduodenectomy versus open pancreaticoduodenectomy–a comparative study. Int J Surg 10:475–479
pubmed: 22732431
Addeo P, Delpero JR, Paye F et al (2014) Pancreatic fistula after a pancreaticoduodenectomy for ductal adenocarcinoma and its association with morbidity: a multicentre study of the French Surgical Association. HPB (Oxford) 16:46–55
Kimura W, Miyata H, Gotoh M et al (2014) A pancreaticoduodenectomy risk model derived from 8575 cases from a national single-race population (Japanese) using a web-based data entry system: the 30-day and in-hospital mortality rates for pancreaticoduodenectomy. Ann Surg 259:773–780
pubmed: 24253151
Kornaropoulos M, Moris D, Beal EW et al (2017) Total robotic pancreaticoduodenectomy: a systematic review of the literature. Surg Endosc 31:4382–4392
pubmed: 28389798
Lei P, Wei B, Guo W et al (2014) Minimally invasive surgical approach compared with open pancreaticoduodenectomy: a systematic review and meta-analysis on the feasibility and safety. Surg Laparosc Endosc Percutan Tech 24:296–305
pubmed: 24743678
Marino MV, Podda M, Gomez Ruiz M et al (2019) Robotic-assisted versus open pancreaticoduodenectomy: the results of a case-matched comparison. J Robot Surg. https://doi.org/10.1007/s11701-019-01018-w
doi: 10.1007/s11701-019-01018-w pubmed: 31473878
Kazanjian KK, Hines OJ, Duffy JP et al (2008) Improved survival following pancreaticoduodenectomy to treat adenocarcinoma of the pancreas: the influence of operative blood loss. Arch Surg 143:1166–1171
pubmed: 19075167
Podda M, Thompson J, Kulli CTG et al (2017) Vascular resection in pancreaticoduodenectomy for periampullary cancers. A 10 year retrospective cohort study. Int J Surg 39:37–44
pubmed: 28110027
Kulemann B, Hoeppner J, Wittel U et al (2015) Perioperative and long-term outcome after standard pancreaticoduodenectomy, additional portal vein and multivisceral resection for pancreatic head cancer. J Gastrointest Surg 19:438–444
pubmed: 25567663
Ravikumar R, Sabin C, Abu Hilal M et al (2014) Portal vein resection in borderline resectable pancreatic cancer: a United Kingdom multicenter study. J Am Coll Surg 218:401–411
pubmed: 24484730
Shyr BU, Chen SC, Shyr YM et al (2019) Surgical, survival, and oncological outcomes after vascular resection in robotic and open pancreaticoduodenectomy. Surg Endosc. https://doi.org/10.1007/s00464-019-06779-x
doi: 10.1007/s00464-019-06779-x pubmed: 30963260

Auteurs

Mauro Podda (M)

Department of General, Emergency and Minimally Invasive Surgery, Policlinico Universitario "D. Casula", University of Cagliari, SS 554, Km 4,500, 09042, Monserrato, Cagliari, Italy. mauropodda@ymail.com.

Chiara Gerardi (C)

Centro Di Politiche Regolatorie in Sanità, IRCCS - Istituto di Ricerche Farmacologiche ''Mario Negri'', Milan, Italy.

Salomone Di Saverio (S)

Department of Surgery, Addenbrooke's Hospital, Cambridge University Hospital NHS Foundation Trust, Cambridge, UK.

Marco Vito Marino (MV)

Department of General and Emergency Surgery, Azienda Ospedaliera - Ospedali Riuniti Villa Sofia-Cervello, Palermo, Italy.

R Justin Davies (RJ)

Department of Surgery, Addenbrooke's Hospital, Cambridge University Hospital NHS Foundation Trust, Cambridge, UK.

Gianluca Pellino (G)

Department of Advanced Medical and Surgical Sciences, Università Della Campania "Luigi Vanvitelli", Naples, Italy.

Adolfo Pisanu (A)

Department of General, Emergency and Minimally Invasive Surgery, Policlinico Universitario "D. Casula", University of Cagliari, SS 554, Km 4,500, 09042, Monserrato, Cagliari, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH